https://mail.parkgroveip.co.uk/latest-news/a-brave-new-world-for-supplementary-protection-certificates- en 2020-02-11T15:08:53+00:00 https://mail.parkgroveip.co.uk/latest-news/a-landmark-case-for-second-medical-use-patents-in-the-uk en 2020-02-17T17:16:06+00:00 https://mail.parkgroveip.co.uk/latest-news/an-unwelcome-development-for-innovators-in-a-key-case-on-spcs en 2020-02-17T17:16:29+00:00 https://mail.parkgroveip.co.uk/latest-news/difficult-questions-important-answers-the-latest-case-on-spcs en 2020-02-11T14:57:59+00:00 https://mail.parkgroveip.co.uk/latest-news/enforcement-of-second-medical-use-patents-landmark-case-sets-the-scene-for-future-battles en 2021-01-29T09:02:26+00:00 https://mail.parkgroveip.co.uk/latest-news/europe-is-now-poised-to-award-longer-terms-to-some-spcs en 2020-02-17T17:16:17+00:00 https://mail.parkgroveip.co.uk/latest-news/european-court-ruling-on-spcs-brings-relief-to-industry en 2020-02-11T14:47:52+00:00 https://mail.parkgroveip.co.uk/latest-news/every-cloud-has-a-silver-lining-portugal-s-loss-may-be-the-uk-s-gain en 2020-02-11T14:52:26+00:00 https://mail.parkgroveip.co.uk/latest-news/every-day-counts-why-pharmaceutical-companies-in-the-eu-need-to-make-sure-they-get-the-right-spc-term en 2020-02-11T15:09:37+00:00 https://mail.parkgroveip.co.uk/latest-news/g-3-19-a-need-to-improve-the-perception-of-independence-of-the-epo-boards-of-appeal- en 2021-01-28T16:54:43+00:00 https://mail.parkgroveip.co.uk/latest-news/g-3-19-do-flaws-in-the-eba-s-reasoning-amplify-concerns-regarding-the-perception-of-independence-of-the-epo-boards-of-appeal- en 2021-01-29T09:01:01+00:00 https://mail.parkgroveip.co.uk/latest-news/hopes-rise-for-a-bright-future-for-paediatric-spc-extensions-in-the-eu en 2020-02-11T14:46:13+00:00 https://mail.parkgroveip.co.uk/latest-news/making-the-most-of-paediatric-spc-extensions-1 en 2020-02-11T14:46:30+00:00 https://mail.parkgroveip.co.uk/latest-news/making-the-most-of-paediatric-spc-extensions en 2020-02-11T14:46:38+00:00 https://mail.parkgroveip.co.uk/latest-news/master-the-detail-to-get-the-most-from-spcs en 2020-02-11T14:48:59+00:00 https://mail.parkgroveip.co.uk/latest-news/neurim-wins-the-battle-but-not-yet-the-war-for-innovators en 2020-02-11T15:08:30+00:00 https://mail.parkgroveip.co.uk/latest-news/novartis-decision-completes-a-new-model-for-spcs-in-eu en 2020-02-11T14:49:28+00:00 https://mail.parkgroveip.co.uk/latest-news/patentability-of-plants-under-the-epc-act-in-haste-repent-at-leisure- en 2021-01-29T09:03:04+00:00 https://mail.parkgroveip.co.uk/latest-news/patentability-of-plants-under-the-epc-back-to-square-one- en 2020-02-11T15:04:11+00:00 https://mail.parkgroveip.co.uk/latest-news/supplementary-protection-certificates-is-a-new-era-beckoning-for-combination-drugs-in-the-eu- en 2020-02-11T14:46:01+00:00 https://mail.parkgroveip.co.uk/latest-news/supplementary-protection-certificates-the-cjeu-issues-its-decision-in-two-seminal-cases en 2020-02-11T14:48:30+00:00 https://mail.parkgroveip.co.uk/latest-news/supplementary-protection-certificates-the-court-of-justice-of-the-eu-will-have-its-day-after-all en 2020-02-11T15:06:16+00:00 https://mail.parkgroveip.co.uk/latest-news/supplementary-protection-certificates-the-never-ending-saga-of-article-3-a- en 2020-02-11T15:06:48+00:00 https://mail.parkgroveip.co.uk/latest-news/the-cjeu-for-supplementary-protection-certificates-who-needs-it- en 2020-02-11T14:52:58+00:00 https://mail.parkgroveip.co.uk/latest-news/the-cjeu-calls-extra-time-for-spcs-but-there-may-be-further-battles-ahead-for-companies en 2020-02-11T14:57:32+00:00 https://mail.parkgroveip.co.uk/latest-news/the-cjeu-s-latest-ruling-on-article-3-a-case-closed- en 2021-01-28T16:54:22+00:00 https://mail.parkgroveip.co.uk/latest-news/the-court-of-justice-clarifies-certain-provisions-governing-parallel-importation en 2020-02-17T17:15:58+00:00 https://mail.parkgroveip.co.uk/latest-news/the-european-commission-submits-its-views-in-an-important-case-for-spcs-to-biologics en 2020-02-17T17:15:32+00:00 https://mail.parkgroveip.co.uk/latest-news/the-latest-case-on-spcs-the-cjeu-rules-in-favour-of-chaos en 2021-01-29T15:57:22+00:00 https://mail.parkgroveip.co.uk/latest-news/the-likely-impact-of-brexit-on-patents-and-spcs-in-the-uk en 2020-02-11T15:03:02+00:00 https://mail.parkgroveip.co.uk/latest-news/three-cjeu-decisions-that-answer-some-questions-but-pose-many-more en 2020-02-11T15:07:34+00:00 https://mail.parkgroveip.co.uk/latest-news/what-is-the-term-of-a-european-patent- en 2021-01-29T09:02:08+00:00 https://mail.parkgroveip.co.uk/latest-news/when-public-policies-collide-the-battle-to-enforce-second-medical-use-patents-for-drugs-in-europe en 2020-02-11T15:05:34+00:00 https://mail.parkgroveip.co.uk/latest-news/you-can-count-on-us-uk-ipo-agrees-to-award-longer-term-to-some-spcs en 2020-02-11T15:08:01+00:00